Pancreatic Cancer Research

ResearcherSir Run Run Shaw HospitalActive in the last 2 years

Xiaolong Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1236-1332; OpenAlex author ID A5100393830. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 1 paper

Papers 2

  1. Icaritin and lenvatinib treatment for unresectable localized progressive pancreatic cancer: a report of six cases. Co-author DOI 10.1080/07853890.2025.2512436↗
  2. Case report: A case study on the treatment using icaritin soft capsules in combination with lenvatinib achieving impressive PR and stage reduction in unresecta… Co-author DOI 10.3389/fgene.2023.1167470↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Guixing Jiang · 1 shared paper, 2025 · strength 0.28
  2. Defei Hong · 1 shared paper, 2025 · strength 0.28
  3. Jianguo Lu · 1 shared paper, 2025 · strength 0.28
  4. Zhengrong Wu · 1 shared paper, 2023 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.